Korean Journal of Food Science and Technology (한국식품과학회지)

Korean Society of Food Science and Technology (한국식품과학회)
권호 표지
DOI QR코드

DOI QR Code

Anti-inflammatory activities of fermented Rhus verniciflua stem bark extract and its growth inhibitory effect on Helicobacter pylori

발효옻 추출물의 헬리코박터파이로리 생장억제 및 항염증 활성

  • Choi, Eun Yeong (Applied Plant Sciences Program, Kangwon National University) ;
  • Suk, Ki Tae (Department of Internal Medicine, Hallym University College of Medicine) ;
  • Choi, Han Seok (Fermented Food Science Division, National Academy of Agricultural Science, RDA) ;
  • Kim, Myung Kon (Department of Food Science and Technology, Chonbuk National University) ;
  • Kwon, Yong Soo (Department of Pharmacy, Kangwon National University) ;
  • Kim, Myong Jo (Bioherb Research Institute, Kangwon National University)
  • 최은영 (강원대학교 식물자원응용과학전공) ;
  • 석기태 (한림대학교 의과대학 내과학교실) ;
  • 최한석 (농촌진흥청 국립농업과학원 발효식품과) ;
  • 김명곤 (전북대학교 식품공학과) ;
  • 권용수 (강원대학교 약학과) ;
  • 김명조 (강원대학교 한방바이오연구소)
  • Received : 2016.05.18
  • Accepted : 2016.06.21
  • Published : 2016.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

This study was designed to investigate the beneficial effects of fermented Rhus verniciflua stem bark extract (RVSBE) on the stomach. We evaluated RVSBE for its antimicrobial activity against Helicobacter pylori (H. pylori), along with its ability to reduce the viability of human gastric cancer AGS cells. In addition, its anti-inflammatory effect was examined by evaluating nitric oxide (NO) production, and inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX)-2 mRNA expression in lipopolysaccharide (LPS)-stimulated RAW264.7 cells. RVSBE showed antimicrobial activity, as 2.0 mg of the extract produced a clear inhibition zone of 4.0 mm. RVSBE inhibited the growth of AGS cells by 20% at concentrations ranging from 0.25-1.0 mg/mL. Regarding the anti-inflammatory effects of RVSBE, at 0.1-1.0 mg/mL, the extract showed more than 75% inhibition of NO production. In addition, cells treated with 0.25 mg/mL RVSBE showed a 25% decrease in iNOS mRNA levels compared to those in the LPS-treated cells. These results suggest that RVSBE may have significant inhibitory effects on inflammatory mediators, and therefore, may be a potential anti-inflammatory candidate.

본 연구는 장수버섯(Fomitella fraxinea)을 이용하여 발효처리 한무독화 옻나무 추출물의 위장기능 개선능을 확인하고자 발효옻추출물을 이용하여 H. pylori 생장억제활성, 위암세포 생장억제활성과 항염증 활성을 평가하였다. H. pylori를 접종한 배지에 발효옻 추출물을 농도별로 첨가하였을 때 2.0 mg의 농도에서 4.0 mm의 생장억제환을 확인하였으며, 발효옻 추출물을 배지에 1.0-5.0 mg 농도로 혼합한 후 H. pylori을 접종한 경우에도 생장억제능이 확인되었다. 이를 바탕으로 세포 수준에서 H. pylori에 의해 유발된다고 알려진 위암과 위염 개선능을 평가하고자 세포독성을 나타내지 않은 0.1-1.0 mg/mL의 농도범위로 AGS 위암세포 생장억제활성 및 NO 생성 저해율을 확인하였다. 실험결과 0.25 mg/mL 이상의 농도에서 20% 이상의 위암세포 생장억제활성을 확인하였으며, LPS로 염증을 유도한 RAW 264.7 세포에서 추출물 0.25 mg/mL처리시 90%의 높은 NO 생성 저해율을 확인하였다. 염증유발인자인 iNOS와 COX-2의 발현 억제율은 0.50 mg/mL 농도에서 각각 50, 10%의 억제율을 보여 NO 생성저해율은 iNOS에 의한 영향인 것으로 사료된다. 상기 결과로 발효옻 추출물은 H. pylori 생장억제능 및 높은 NO 생성저해 활성이 확인됨으로서 간접적인 위암발생 억제제 및 항염증제로서의 이용가능성을 확인하였다. 따라서 발효옻 추출물을 이용한 위장개선 식의약 소재로서의 개발 가능성이 매우 높은 것으로 생각되며 이를 위해 추가적인 연구가 진행되어야 할 것으로 사료된다.

Keywords

References

  1. Lee JJ, Kim SH, Chang BS, Lee JB, Huh CS, Kim TJ, Baek YJ. The antimicrobial activity of medicinal plants extracts against Helicobacter pylori. Korean J. Food Sci. Technol. 31: 764-770 (1999)
  2. Lee BW, Choi MS, Yim DS, Choi SS. In vitro anti-Helicobacter pylori activity of ethanol extract of Sohamhyoongtang and Coptidis Rhizoma total alkaloids. Kor. J. Pharmacogn. 45: 168-173 (2014)
  3. Yim JY, Kim NY, Choi SH, Kim YS, Cho KR, Kim SS, Seo GS, Kim HU, Baik GH, Sin CS, Cho SH, Oh BH. Seroprevalence of Helicobacter pylori in South Korea. Helicobacter 12: 333340 (2007)
  4. Kim YS, Baik GH. Epidemiology of Helicobacter pylori infection in Korea. Korean J. Helicobacter Up. Gastrointest. Res. 11: 1-6 (2011) https://doi.org/10.7704/kjhugr.2011.11.1.1
  5. Oh HG, Moon DI, Kim JH, Kang YR, Park JW, Seo MY, Park SH, Kang YG, Choe CH, Park IS, Kim J, Yu KY, Seol ED, Kim OJ, Lee HY. The effects of sea cucumber as an anti-gastritis, anti-gastric ulcer, and anti-Helicobater. J. Korean Soc. Food Sci. Nutr. 41: 605-611(2012) https://doi.org/10.3746/jkfn.2012.41.5.605
  6. Oh HC. Promoter methylation of COX-2 and E-cadherin in patients with Helicobacter pyloriinfected atrophic gastritis. PhD thesis, Kyunghee University, Seoul, Korea (2007)
  7. Yoon BJ. Phamacological evaluation on anti-inflammatory effects of the flavonoids isolated from the heartwood of Rhus verniciflua Stokes. MS thesis, Kyungsung University, Busan, Korea (2001)
  8. Choi WS. Effect of extraction conditions on anti-inflammatory activity and index compounds content in Rhus verniciflua Stokes extract. MS thesis, Chungbuk National University, Cheongju, Korea (2014)
  9. Kim SS, Chung JM. Taxonomic characteristics of Korean-native anacardiaceae. J. Korean For. Soc. 84: 151-165 (1995)
  10. Choi HS, Kim MK, Park HS, Yun SE, Mun SP, Kim JS, Sapkota K, Kim S, Kim TY, Kim SJ. Biological detoxification of lacquer tree (Rhus verniciflua Stokes) stem bark by mushroom species. Food Sci. Biotechnol. 16: 935-942 (2007)
  11. Hong SH, Han MH, Choi YH, Park SE. Induction of p53-dependent G1 cell cycle arrest by Rhus verniciflua Stokes extract in human breast carcinoma MCF-7 cells. J. Int. Korean Med. 36: 13-21 (2015)
  12. Choi HS, Yeo SH, Jeong ST, Choi JH, Park HS, Kim MK. Preparation and characterization of urushiol free fermented Rhus verniciflua stem bark (FRVSB) extracts. Korean J. Food Sci. Technol. 44: 173-178 (2012) https://doi.org/10.9721/KJFST.2012.44.2.173
  13. Choi EY, Yang J, Lee CO, Lee YJ, Han HM, Kwon YS, Choi HS, Suk KT, Kim MJ. Urushiol confirmation, and antioxidant activities at different extraction conditions of fermented Rhus verniciflua in ogcheon area (acstract no P03-027). May 13-14, In: The Korean Society of Medicinal Crop Science Symposium and Spring Conference. Chungnam National University, Daejeon, Korea. The Korean Society of Medicinal Crop Science, Eumseong, Korea (2014)
  14. Cho YJ, Ju IS, Kim BC, Lee WS, Kim MJ, Lee BG, An BJ, Kim JH, Kwon OJ. Biological activity of omija (Schizandra chinensis Baillon) extracts. J. Korean Soc. Appl. Bi. 50: 198-203 (2007)
  15. Kim SY. The suppressive effect of acetic acid on Helicobacter pylori. MS thesis, Konkuk University, Seoul, Korea (2010)
  16. Song YG. Overview of Helicobacter pylori and treatment options. Econ. Environ. Geol. 48: 241-246 (2015) https://doi.org/10.9719/EEG.2015.48.3.241
  17. Choi HS. Biological removal of urushiol from Rhus verniciflua stokes (RVS) and investigation of the detoxified RVS. PhD thesis, Chonbuk National University, Jeonju, Korea (2007)
  18. Lim BR, Lee HJ, Kim MC, Kim BJ. Effects of Ulmi pumilae cortex on AGS gastric cancer cells. J. Pharmacopunct. 16: 055- 061 (2013)
  19. Lee SH, Jin SY, Lee DW. Expression of nitrotyrosine and apoptosis in Helicobacter pylori gastritis adjacent to the peptic ulcer, gastric adenoma, and adenocarcinoma. J. Soonchunhyang Med. Coll. 7: 143-153 (2001)
  20. Mannick EE, Bravo LE, Zarama G, Realpe JL, Zhang XJ, Ruiz B, Fontham ETH, Mera R, Miller MJS, Correa P. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res. 56: 3238-3243 (1996)
  21. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmac. Rev. 43: 109-142 (1991)
  22. Kim JH. Study on the cell bioactive characteristics of fermented Rhus verniciflua Stem bark extracts through bioconversion. PhD thesis, Konkuk University, Seoul, Korea (2016)
  23. Choi EY, Heo SI, Kwon YS, Kim MJ. Anti-oxidant activity and anti-inflammatory effects of Spiraea fritschiana Schneid extract. Korean J. Medicinal Crop Sci. 24: 3137 (2016)
  24. Yoon YI, Chang MY, Hwang JS, Goo TW, Ahn MY, Lee YB, Han MS, Yun EY. Anti-inflammatory effect of Oxya chinensis sinuosa ethanol extract in LPS-induced RAW 264.7 cells. J. Life Sci. 24: 370-376 (2014) https://doi.org/10.5352/JLS.2014.24.4.370
  25. Yamagishi M, Noda M, Tatsumi Y, Mukaisho K, Mitsufuji S, Sugihara H, Okanoue T, Hattori T. Correlation between cyclooxygenase-2, proliferative activity, and mucin phenotype in human advanced gastric cancer. J. Gastroenterol. 39: 1143-1149 (2004) https://doi.org/10.1007/s00535-004-1463-1